November 14, 2016
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on November 11 supported approval for Ono Pharmaceutical’s anti-PD-1 antibody Opdivo (nivolumab) for an additional indication of Hodgkin’s lymphoma. The Pharmaceutical Affairs and Food Sanitation Council’s Second...read more